IL140550A - Methods for early diagnosis of carcinomas - Google Patents
Methods for early diagnosis of carcinomasInfo
- Publication number
- IL140550A IL140550A IL14055099A IL14055099A IL140550A IL 140550 A IL140550 A IL 140550A IL 14055099 A IL14055099 A IL 14055099A IL 14055099 A IL14055099 A IL 14055099A IL 140550 A IL140550 A IL 140550A
- Authority
- IL
- Israel
- Prior art keywords
- carcinomas
- early diagnosis
- methods
- overexpression
- cell cycle
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57411—Specifically defined cancers of cervix
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19829473A DE19829473C2 (de) | 1998-07-01 | 1998-07-01 | Verfahren zur frühen Diagnose von Carcinomen |
| PCT/DE1999/002094 WO2000001845A2 (fr) | 1998-07-01 | 1999-07-01 | Methode de diagnostic precoce de carcinomes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL140550A0 IL140550A0 (en) | 2002-02-10 |
| IL140550A true IL140550A (en) | 2005-08-31 |
Family
ID=7872684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14055099A IL140550A (en) | 1998-07-01 | 1999-07-01 | Methods for early diagnosis of carcinomas |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6709832B1 (fr) |
| EP (1) | EP1092155B1 (fr) |
| JP (1) | JP3404020B2 (fr) |
| KR (1) | KR100646193B1 (fr) |
| CN (1) | CN1209627C (fr) |
| AT (1) | ATE230487T1 (fr) |
| AU (1) | AU749769B2 (fr) |
| BR (1) | BRPI9912227B8 (fr) |
| CA (1) | CA2336153C (fr) |
| CZ (1) | CZ292076B6 (fr) |
| DE (2) | DE19829473C2 (fr) |
| DK (1) | DK1092155T3 (fr) |
| ES (1) | ES2190820T3 (fr) |
| HK (1) | HK1038609A1 (fr) |
| HU (1) | HUP0102744A2 (fr) |
| IL (1) | IL140550A (fr) |
| MX (1) | MXPA00012852A (fr) |
| NO (1) | NO328685B1 (fr) |
| PL (1) | PL198623B1 (fr) |
| RU (1) | RU2217761C2 (fr) |
| SK (1) | SK284056B6 (fr) |
| TR (1) | TR200003903T2 (fr) |
| WO (1) | WO2000001845A2 (fr) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7306926B2 (en) * | 1998-07-01 | 2007-12-11 | Mtm Laboratories Ag | Method for detecting carcinomas in a solubilized cervical body sample |
| AUPP991199A0 (en) * | 1999-04-21 | 1999-05-13 | University Of Sydney, The | Methods for diagnosing pre-cancerous and cancerous conditions |
| DE10006033B4 (de) * | 2000-02-10 | 2005-11-10 | Professor Dr. Magnus von Knebel Doeberitz Chirurgische Universitätsklinik Sektion für Molekulare Diagnostik und Therapie | Immunisierung eines Individuums gegen Carcinome und ihre Vorstufen |
| US9249229B2 (en) | 2000-12-08 | 2016-02-02 | Alexion Pharmaceuticals, Inc. | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| US20060057651A1 (en) * | 2000-12-08 | 2006-03-16 | Bowdish Katherine S | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| US7408041B2 (en) | 2000-12-08 | 2008-08-05 | Alexion Pharmaceuticals, Inc. | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| AUPR201500A0 (en) * | 2000-12-11 | 2001-01-11 | Biosceptre Pty Ltd | Methods for identifying pre-neoplastic and neoplastic states in mammals |
| DE10063179A1 (de) * | 2000-12-18 | 2002-06-20 | Bayer Ag | Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern |
| WO2002057306A1 (fr) * | 2001-01-17 | 2002-07-25 | Intreat Pty Limited | Anticorps du recepteur p2x7 non fonctionnel, diagnostic et traitement de cancers et autres etats pathologiques |
| EP1369694A1 (fr) * | 2002-04-09 | 2003-12-10 | MTM Laboratories AG | Procédé de discrimination entre des métaplasies et des lésions néoplastiques ou préneoplastiques |
| DE60200248T2 (de) * | 2002-08-01 | 2005-01-27 | Mtm Laboratories Ag | Verfahren für Lösung-basierte Diagnose |
| EP1422526A1 (fr) * | 2002-10-28 | 2004-05-26 | MTM Laboratories AG | Procédé ameliorée de diagnostic des dysplasies |
| WO2004070062A2 (fr) * | 2003-02-04 | 2004-08-19 | Wyeth | Compositions et techniques de diagnostic et de traitement de cancers |
| WO2004076686A1 (fr) * | 2003-02-26 | 2004-09-10 | Sysmex Corporation | Procede pour analyser une cellule |
| DE60300339T2 (de) * | 2003-08-25 | 2006-04-13 | Mtm Laboratories Ag | Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben |
| KR20080075045A (ko) * | 2004-03-24 | 2008-08-13 | 트리패스 이미징, 인코포레이티드 | 자궁경부 질환의 검사 방법 및 조성물 |
| US8921057B2 (en) * | 2004-05-31 | 2014-12-30 | Sysmex Corporation | Method of assessing properties of mammalian cells, and method of diagnosing cancer using the same |
| EP1628135A1 (fr) * | 2004-08-20 | 2006-02-22 | MTM Laboratories AG | Procédé pour la détection d'états médicalement pertinants dans des échantillons LBC solubilisés |
| US7892750B1 (en) * | 2004-12-23 | 2011-02-22 | University Of Notre Dame Du Lac | Cathepsin E as a marker of colon cancer |
| JP4766969B2 (ja) | 2005-09-14 | 2011-09-07 | シスメックス株式会社 | 組織性質判定装置 |
| US7972776B2 (en) * | 2005-11-15 | 2011-07-05 | Oncohealth Corporation | Protein chips for HPV detection |
| NZ599035A (en) | 2006-01-12 | 2013-12-20 | Alexion Pharma Inc | Antibodies to ox-2/cd200 and uses thereof |
| AU2007306924A1 (en) * | 2006-10-10 | 2008-04-17 | Biosceptre International Limited | Hybridomas producing antibodies against non functional P2X7 receptor |
| US8968995B2 (en) * | 2008-11-12 | 2015-03-03 | Oncohealth Corp. | Detection, screening, and diagnosis of HPV-associated cancers |
| US20100003704A1 (en) * | 2008-06-13 | 2010-01-07 | Shuling Cheng | IN SITU detection of early stages and late stages HPV infection |
| JP5111902B2 (ja) * | 2007-03-14 | 2013-01-09 | シスメックス株式会社 | 癌の診断支援装置 |
| EP2028600B1 (fr) | 2007-08-24 | 2016-10-26 | Sysmex Corporation | Système de support de diagnostic pour cancer, support de diagnostic pour procédé pour fournir des informations sur un cancer, et produit de programme informatique |
| EP2201377B1 (fr) | 2007-09-14 | 2012-01-18 | Biosceptre International Limited | Récepteurs purinergiques (p2x) dans un liquide organique extracellulaire |
| CA2737126C (fr) | 2007-09-14 | 2018-05-01 | Biosceptre International Limited | Nouveaux epitopes p2x7 |
| CN102143978B (zh) | 2008-07-04 | 2015-02-18 | 生物权威国际有限公司 | 抗p2x7肽和表位 |
| EP2427763A4 (fr) * | 2009-05-07 | 2013-08-21 | Oncohealth Corp | Identification de grade élevée ou cin2 pour détection, surveillance et diagnostic, à des stades précoces et des stades avancés, de papillomavirus humain (hpv) et de cancers associés au hpv |
| EP3395832B1 (fr) | 2009-08-20 | 2021-11-24 | Biosceptre (Aust) Pty Ltd | Anticorps du récepteur anti p2x7 et leurs fragments |
| AU2010336032C1 (en) | 2009-12-24 | 2016-04-21 | Biosceptre International Limited | Antibodies to non-functional oligomeric P2X7 receptors |
| CN102822672B (zh) | 2010-01-08 | 2015-12-09 | 安科健康公司 | 用于诊断和筛选与hpv有关的癌症的高通量细胞基hpv免疫测定 |
| US8900813B2 (en) | 2010-08-17 | 2014-12-02 | Medical Diagnostic Laboratories, Llc | CIP2A as a biomarker in detection of cervical cancer |
| AU2011301153B2 (en) | 2010-09-10 | 2014-11-27 | Biosceptre International Limited | Companion animal treatments |
| US9551700B2 (en) | 2010-12-20 | 2017-01-24 | Milagen, Inc. | Device and methods for the detection of cervical disease |
| JP6305920B2 (ja) | 2011-07-01 | 2018-04-04 | バイオセプター・（オーストラリア）・ピーティーワイ・リミテッド | 併用療法 |
| WO2013067268A1 (fr) | 2011-11-03 | 2013-05-10 | Tripath Imaging, Inc. | Procédés et compositions pour préparer des échantillons en vue d'une coloration immunologique |
| BR112014011563B1 (pt) * | 2011-11-15 | 2022-05-24 | University Of Miami | Método para determinar um risco aumentado de carcinoma de células escamosas de cabeça e pescoço (hnscc) em um indivíduo humano infectado com papiloma vírus humano (hpv), e kit |
| WO2019067499A1 (fr) | 2017-09-27 | 2019-04-04 | Alexion Pharmaceuticals, Inc. | Signature de biomarqueur pour la prédiction d'une réponse tumorale vis-à-vis d'une thérapie anti-cd200 |
| WO2019234176A1 (fr) | 2018-06-07 | 2019-12-12 | Universitaet Des Saarlandes | Nouveaux biomarqueurs pour le diagnostic du carcinome |
| CN108893534A (zh) * | 2018-06-26 | 2018-11-27 | 华中科技大学鄂州工业技术研究院 | 泛癌症诊断标记物 |
| RU2707884C1 (ru) * | 2018-10-03 | 2019-12-02 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се | Способ ранней диагностики почечно-клеточной карциномы по наличию антител к зрительному аррестину |
| FR3088640A1 (fr) | 2018-10-14 | 2020-05-22 | Smart Diagnostix Pharma | Nouveau polypeptide se liant specifiquement a la proteine p16 |
| CN111257565A (zh) * | 2018-12-03 | 2020-06-09 | 上海细胞治疗集团有限公司 | 一种衰老细胞的检测试剂盒及其检测方法 |
| CN113295683A (zh) * | 2021-05-24 | 2021-08-24 | 烟台海关技术中心 | 过氧化苯甲酰检测方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4281061A (en) * | 1979-07-27 | 1981-07-28 | Syva Company | Double antibody for enhanced sensitivity in immunoassay |
| US5268463A (en) * | 1986-11-11 | 1993-12-07 | Jefferson Richard A | Plant promoter α-glucuronidase gene construct |
| PT665886E (pt) | 1992-10-16 | 2003-10-31 | Cold Spring Harbor Lab | Rearranjo de complexos de ciclina e suas utilizacoes |
| WO1994012881A2 (fr) * | 1992-12-02 | 1994-06-09 | Hochstrasser Denis F | PROCEDE DE DETECTION DE CELLULES EN CROISSANCE A L'AIDE DE PROTEINE TUMORALE p21 REGULEE PAR TRADUCTION |
| US5543291A (en) * | 1993-01-29 | 1996-08-06 | Dana Farber Cancer Institute | Method of detecting carcinoma |
| US6316208B1 (en) * | 1994-01-07 | 2001-11-13 | Memorial Sloan-Kettering Cancer Center | Methods for determining isolated p27 protein levels and uses thereof |
| NZ284612A (en) * | 1994-03-18 | 1997-09-22 | Univ Utah Res Found | Multiple tumour suppressor (mts) gene and its use in the diagnosis and treatment of cancer |
| US5763190A (en) * | 1994-09-21 | 1998-06-09 | The Trustees Of The University Of Pennsylvania | Methods for the identification of compounds capable of inducing the nuclear translocation of a receptor complex comprising the glucocoticoid receptor type II and viral protein R interacting protein |
| US6033847A (en) * | 1995-02-06 | 2000-03-07 | St. Jude Children's Research Hospital | InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof |
| US5976799A (en) | 1996-03-21 | 1999-11-02 | The Board Of Trustees Of The University Of Arkansas | Early detection of ovarian carcinoma using P16 gene products |
| US5851797A (en) * | 1996-06-19 | 1998-12-22 | Regeneron Pharmaceuticals, Inc. | Tie ligand-3, methods of making and uses thereof |
| US5858683A (en) * | 1996-08-30 | 1999-01-12 | Matritech, Inc. | Methods and compositions for the detection of cervical cancer |
| WO2000024245A1 (fr) * | 1998-10-28 | 2000-05-04 | President And Fellows Of Harvard College | REGULATION DE L'ACTIVITE DES CELLULES TH2 PAR MODULATION DE L'ACTIVITE DE NFATp ET DE NFAT4 |
-
1998
- 1998-07-01 DE DE19829473A patent/DE19829473C2/de not_active Expired - Lifetime
-
1999
- 1999-07-01 JP JP2000558235A patent/JP3404020B2/ja not_active Expired - Lifetime
- 1999-07-01 ES ES99945931T patent/ES2190820T3/es not_active Expired - Lifetime
- 1999-07-01 PL PL345407A patent/PL198623B1/pl unknown
- 1999-07-01 US US09/743,103 patent/US6709832B1/en not_active Expired - Lifetime
- 1999-07-01 WO PCT/DE1999/002094 patent/WO2000001845A2/fr active IP Right Grant
- 1999-07-01 KR KR1020017000026A patent/KR100646193B1/ko not_active IP Right Cessation
- 1999-07-01 MX MXPA00012852A patent/MXPA00012852A/es active IP Right Grant
- 1999-07-01 BR BRPI9912227 patent/BRPI9912227B8/pt not_active IP Right Cessation
- 1999-07-01 AU AU58487/99A patent/AU749769B2/en not_active Expired
- 1999-07-01 CZ CZ20004922A patent/CZ292076B6/cs not_active IP Right Cessation
- 1999-07-01 CN CNB998079111A patent/CN1209627C/zh not_active Expired - Lifetime
- 1999-07-01 AT AT99945931T patent/ATE230487T1/de active
- 1999-07-01 SK SK2031-2000A patent/SK284056B6/sk not_active IP Right Cessation
- 1999-07-01 DK DK99945931T patent/DK1092155T3/da active
- 1999-07-01 EP EP99945931A patent/EP1092155B1/fr not_active Expired - Lifetime
- 1999-07-01 RU RU2001102598/15A patent/RU2217761C2/ru active
- 1999-07-01 HU HU0102744A patent/HUP0102744A2/hu unknown
- 1999-07-01 DE DE59903915T patent/DE59903915D1/de not_active Expired - Lifetime
- 1999-07-01 IL IL14055099A patent/IL140550A/xx not_active IP Right Cessation
- 1999-07-01 CA CA002336153A patent/CA2336153C/fr not_active Expired - Lifetime
- 1999-07-01 TR TR2000/03903T patent/TR200003903T2/xx unknown
-
2000
- 2000-12-28 NO NO20006681A patent/NO328685B1/no not_active IP Right Cessation
-
2001
- 2001-10-18 HK HK01107321A patent/HK1038609A1/xx not_active IP Right Cessation
-
2003
- 2003-02-20 US US10/371,883 patent/US20030152993A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL140550A (en) | Methods for early diagnosis of carcinomas | |
| WO2000005265A3 (fr) | Anticorps anti-ccr2 et procedes d'utilisation correspondants | |
| EP1687283A4 (fr) | Procede et composition servant a determiner fk 506 | |
| HK1074670A1 (en) | Sets of digital antibodies directed against short epitopes, and methods using same | |
| MY138674A (en) | Radiolabeling kit and binding assay | |
| WO1999042090A3 (fr) | Traitement du cancer | |
| EP1102988B8 (fr) | Procede d'evaluation de l'activite de la reponse immunitaire du sang et trousse d'essai correspondante | |
| EP1708745A4 (fr) | Anticorps pour des souches oncogenes du hpv et leurs methodes d'utilisation | |
| WO1997008318A3 (fr) | Composes et procedes de traitement et de diagnostic du cancer de la prostate | |
| WO2000035950A3 (fr) | Reactifs et methodes utiles pour la detection des pathologies du sein | |
| SE9604815D0 (sv) | A metod of diagnosis | |
| FR2816410B1 (fr) | Necessaire de detection de la proteine esm-1 et procede de detection mettant en oeuvre ledit necessaire | |
| HK1044190A1 (en) | A method for identifying pre-neoplastic and/or neoplastic states in mammals | |
| AU7571998A (en) | Rapid evaluation of the ratio of biological molecules | |
| CA2366514A1 (fr) | Utilisation a des fins diagnostiques et therapeutiques d'anticorps diriges contre le recepteur de l'urokinase | |
| GB9609653D0 (en) | Method of assay | |
| SE0002835D0 (sv) | Method and kit for production of monoclonal antibodies | |
| AU4865997A (en) | Monoclonal antibodies against a human act and serine protease complex | |
| AU4908799A (en) | Determination of the hydrophobic pulmonary surfactant protein sp-c | |
| AU2002233278A1 (en) | Method and use of the cytosolic nadp-dependent malate-decarboxylase isoenzyme for identifying a malignant process, and a suitable test kit | |
| AU9437598A (en) | Method and kit for identifying interactions between proteins or peptides | |
| NO992531L (no) | Fremgangsmåter ved fremstilling av rekombinant protein | |
| WO2001006226A3 (fr) | Procede pour determiner l'activite de proliferation de cellules | |
| WO1998037092A3 (fr) | Utilisation d'une nouvelle proteine metalloprotease disintegrine, mutants, fragments et analogues de ladite proteine | |
| EP1702984A3 (fr) | Méthode pour la détection du cancer de la prostate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |